Pathologic Correlates of Nondemented Aging, Mild Cognitive Impairment, and Early-Stage Alzheimer's Disease

Cited by (511)

Items 401–500 of 511

1. Links Between Amyloid and Tau Biology in Alzheimer’s Disease and Their Cholinergic Aspects
   George J. Siegel, Neelima B. Chauhan, Alexander G. Karczma · 2007 · Springer eBooks
2. Deterioro cognitivo leve
   Olga Bruna Rabassa, Carmelo Pelegrín Valero, David Bartrés‐Faz, Nina Gramunt, Judit Subirana Mirete, Anna Dergham · 2011 · Elsevier eBooks
3. A verbális fluencia és a munkamemória életkori változásai és szerepük az iskolai teljesítményben
   Tímea Tánczos · 2014
4. Detection of severity in Alzheimer’s disease (AD) using computational modeling
   Hyun‐Jo Kim · 2018 · Bioinformation
5. NREM delta power and AD-relevant tauopathy are associated with shared cortical gene networks
   Joseph R. Scarpa, Peng Jiang, Vance Gao, Martha Hotz Vitaterna, Fred William Turek, Andrew Kasarskis · 2021 · Scientific Reports
6. The Clinical Use of SPECT and PET Molecular Imaging in Alzheimer’s Disease
   Varvara J Valotassiou, Nikolaos Sifakis, John D. Papatriantafyllou, George Angelidis, Panagiotis Georgoulias · 2011 · InTech eBooks
7. Neuroimaging Findings in Mild Cognitive Impairment
   F. Massa, M. Bauckneht, E. Peira, C. Lapucci, A. Picco, S. Capitanio, D. Arnaldi, L. Roccatagliata, A. Chincarini, F. Nobili · 2020 · PET and SPECT in Neurology
8. Deterioro cognitivo: clasificación mediante espectroscopia de resonancia magnética de protón y contribución de la imagen convencional
   M. Carmen Martínez‐Bisbal, Estanislao Arana, Luis Martí‐Bonmatí, Beatriz Martínez-Granados, Bernardo Celda · 2006 · Radiología
9. [Resistine--a new hormone secreted by adipose tissue (adipose tissue in insulin resistance)].
   Zdzisław Kochan, Joanna Karbowska · 2003 · PubMed
10. Diagnosis at the tip of the tongue
    Barbara M. van der Sluijs · 2006 · Journal of Neurology Neurosurgery & Psychiatry
11. Quantitative Approaches to Amyloid Imaging
    Victor L. Villemagne, Graeme Joseph O'Keefe, Rachel S. Mulligan, Christopher Cleon Rowe · 2010 · Methods in molecular biology
12. 14 Amyloid Imaging and (What is “Normal”?) Aging
    William Edward Klunk, Chester A. Mathis · 2009 · Oxford University Press eBooks
13. Olfactory Dysfunction and Cognitive Impairment
    Jung‐Seok Lee, SangYun Kim, Jeong‐Whun Kim · 2007
14. A General Linear Mixed Effect Model to Infer Biomarker Correlations by Bridging Retrospectively Measured Data Across Multiple Studies
    Chengjie Xiong, Ruijin Lu, David A. Wolk, Leslie M. J. Shaw, Carey Elizabeth Gleason, Sterling C. Johnson, Folasade Agboola, Suzanne E. Schindler, John C. Morris, Jingqin Rosy Luo · 2025 · Statistics in Medicine
15. Musicoterapia como intervenção não-farmacológica na doença de Alzheimer: uma revisão integrativa
    Beatriz Gonçalves Cosmo, Giulia de Menezes Vervloet, João Pedro Machado Rocha, Mylena Pimentel Klein, Raquel Santos Silva, Valdir Ribeiro Campos · 2022 · Revista de Medicina
16. Differential centiloid scale normalization techniques: comparison between hybrid PET/MRI and independently acquired MRI
    Ryo Yamakuni, Takenobu Murakami, Naoyuki Ukon, Takeyasu Kakamu, Wataru Toda, Kasumi Hattori, Hirofumi Sekino, Shiro Ishii, Kenji Fukushima, Hiroshi Matsuda et al. · 2024 · Annals of Nuclear Medicine
17. Nutrients and mild cognitive impairment: Food for thought
    Marzena Ułamek-Kozioł, Stanisław Jerzy Czuczwar, Ryszard M. Pluta · 2016 · Nutrition
18. Neuropsychiatric Symptoms in Patients with Mild Cognitive Impairment and Dementia of Alzheimer's Type
    Ram Hwangbo, Hyun Kim, Kang Joon Lee · 2012 · 精神身體醫學 = Korean journal of psychosomatic medicine
19. Targeted Metabolomic Analysis of the Eye Tissue of Triple Transgenic Alzheimer’s Disease Mice at an Early Pathological Stage
    Liming Shen, Xiaoxiao Tang, Huajie Zhang, Hongbin Zhuang, Lin Jing, Yuxi Zhao, Xukun Liu · 2023 · Molecular Neurobiology
20. T1 and FLAIR signal intensities are related to tau pathology in dominantly inherited Alzheimer disease
    Farzaneh Rahmani, Matthew R. Brier, Brian Andrew Gordon, Nicole Sarah McKay, Shaney E. Flores, Sarah Keefe, Russ C. Hornbeck, Beau M. Ances, Nelly Joseph‐Mathurin, Chengjie Xiong et al. · 2023 · Human Brain Mapping
21. Aβ Imaging in Aging, Alzheimer’s Disease and Other Neurodegenerative Conditions
    Victor L. Villemagne, Michelle T. Fodero‐Tavoletti, Paul A Yates, Colin Louis Masters, Christopher Cleon Rowe · 2014 · Springer eBooks
22. Neuroimaging Findings in Mild Cognitive Impairment
    Federico Massa, Matteo Bauckneht, Enrico Peira, Caterina Lapucci, Agnese Picco, Selene Capitanio, Dario Arnaldi, Luca Roccatagliata, A. Chincarini, Flavio Mariano Nobili · 2020 · Springer eBooks
23. Neurobiologische Frühdiagnostik der Alzheimer-Krankheit
    Harald Juergen Hampel, Stefan Teipel, Katharina Bürger · 2007 · Der Nervenarzt
24. Extracellular Amyloid-β Protein Dynamics in Alzheimer’s Disease
    John R. Cirrito · 2012 · AAPS advances in the pharmaceutical sciences series
25. Alzheimer's Disease Longitudinal Change in CSF Biomarkers in Autosomal-Dominant
    Anne M. Fagan · 2014
26. Structural brain characteristics and gene co-expression analysis: A study with outcome label from normal cognition to mild cognitive impairment
    Suping Cai, Fan Yang, Xuwen Wang, Sijia Wu, Liyu Huang · 2022 · Neurobiology of Learning and Memory
27. Modified RCTU Score: A Semi-Quantitative, Visual Tool for Predicting Alzheimer’s Conversion from aMCI
    Ari Chong, Jung‐Min Ha, Ji Yeon Chung, Hoowon Kim, Il Han Choo · 2024 · Brain Sciences
28. Alzheimer's Disease: Clinical Features, Neuropathologies and Biochemical Abnormalities, Genetics, Models, and Experimental Therapeutics
    Donald L. Price, David Borchelt, Philip C. Wong · 2005 · Elsevier eBooks
29. Increasing the confidence of 18F-Florbetaben PET interpretations: Machine learning quantitative approximation
    Ana María García Vicente, María Jesús Tello Galán, Francisco José Pena Pardo, Mariano Amo‐Salas, Beatriz Mondejar Marín, Santiago Navarro Muñoz, Ignacio Rueda Medina, Víctor Manuel Poblete García, Carlos Marsal Alonso, Á. Soriano Castrejón · 2021 · Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
30. Alzheimer’s disease and atherosclerosis: Passers-by or brothers?
    Yu Xing, Shui‐Ping Zhao, Rong Xiang · 2009 · Medical Hypotheses
31. Neuropathology of HIV-1 Disease
    Virawudh Soontornniyomkij · 2017 · Springer eBooks
32. F2-Isoprostanes as Biomarkers of Late Onset Alzheimer’s Disease
    Joseph F. Quinn, Jason D. Morrow, Thomas Jude Montine, Jeffrey Alan Kaye · 2005 · Oxidative stress and disease
33. Amyloid β and Alzheimer disease therapeutics: the devil may be in the details
    John R. Cirrito, David M. Holtzman · 2003 · Journal of Clinical Investigation
34. Subsets of a Large Cognitive Battery Better Power Clinical Trials on Early Stage Alzheimer's Disease
    Chengjie Xiong, Hua Weng, David Alan Bennett, Patricia A. Boyle, Raj C. Shah, Scot Fague, Charles B. Hall, Richard B. Lipton, John C. Morris · 2014 · Neuroepidemiology
35. Hippocampal atrophy in Alzheimer’s disease
    H. Soininen, Yawu Liu, D. Rueckert, J. Lötjönen · 2012 · Neurodegenerative Disease Management
36. Multi-domain Cognitive Testing
    John Preetham Gurja, Suriya Prakash Muthukrishnan, Manjari Tripathi, Nalin Mehta, Ratna Sharma · 2022 · Neurology India
37. The role of the Alzheimer's Disease Neuroimaging Initiative in establishing the Dominantly Inherited Alzheimer Network
    John C. Morris, Virginia Buckles · 2024 · Alzheimer s & Dementia
38. Chapter 3 Mild Cognitive Impairment
    Gregory A. Jicha, Ronald Carl Petersen · 2007 · Blue books of neurology
39. Clinical Effects of Sex Steroids on the Brain
    Ivaldo Silva, Frederick Nicholas Naftolin · 2007 · Elsevier eBooks
40. N-Methyl-D-Aspartate Receptors Mediate Excitotoxicity in Amyloid Beta-Induced Synaptic Pathology of Alzheimer’s Disease
    Jinping Liu, Xiulai Gao, Yan Wu · 2008 · Neuroembryology and Aging
41. The Challenge and Public Health Implications of Alzheimer Overdiagnosis in the Oldest Old
    Majid Fotuhi · 2010 · Archives of Neurology
42. Mild cognitive impairment: evaluation and prospects
    Jacques Touchon, Florence Portet · 2004 · Psychogeriatrics
43. Elevated tau PET signal depends on abnormal amyloid levels and is uncommon in unimpaired individuals
    Brian Andrew Gordon, Betty Marije Tijms · 2019 · Brain
44. Neurodegenerative Biomarkers in Healthy Elderly - with special reference to the preclinical pattern of biological and cognitive markers for Alzheimer’s disease
    Erik Stomrud · 2009 · Lund University Publications (Lund University)
45. β-Amyloid Imaging In Vivo and Its Possible Implications for Alzheimer’s Disease
    Nicolaas P. L. G. Verhoeff, Alan A. Wilson, Hank F. Kung, Douglas Hussey, Liat Trop, Sylvain Houle · 2004 · Springer eBooks
46. Aβ Imaging in Aging, Alzheimer’s Disease, and Other Neurodegenerative Conditions
    Victor L. Villemagne, Vincent Doré, Samantha C. Burnham, Christopher Cleon Rowe · 2020 · Springer eBooks
47. Cost-utility analysis of cerebrospinal fluid versus blood biomarkers for early detection of Alzheimer’s disease and mild cognitive impairment in Thailand: a modeling study
    Pattara Leelahavarong, Juthamas Prawjaeng, Pakkanan Angkab, Natthamon Wongkom, Philip Scheltens, Varalak Srinonprasert, Vorapun Senanarong · 2026 · BMC Health Services Research
48. Place cell physiology in a transgenic mouse model of Alzheimer's disease
    Ming Yi · 2009
49. The Dementias
    Steven Trent DeKosky, Daniel Kaufer, Ronald L. Hamilton, David A. Wolk, Oscar L. López · 2008 · Elsevier eBooks
50. Clinical Evaluation of Dementia and When to Perform PET
    Linda M. Ercoli, Gary W. Small · 2009 · Springer eBooks
51. Cerebrospinal Fluid β-Amyloid 42, Tau, and P-tau
    David M. Holtzman · 2009 · Archives of Neurology
52. Aumento de la confianza en la interpretación del PET con 18F-Florbetaben: “machine learning” basado en la aproximación cuantitativa
    Ana María García Vicente, María Jesús Tello Galán, Francisco José Pena Pardo, Mariano Amo‐Salas, B. Mondejar Marín, Santiago Navarro Muñoz, Ignacio Rueda Medina, Víctor Manuel Poblete García, Carlos Marsal Alonso, Á. Soriano Castrejón · 2021 · Revista Española de Medicina Nuclear e Imagen Molecular
53. Alzheimer’s Disease
    Massimo Filippi, Federica Agosta · 2021 · Springer eBooks
54. Copolymer-1 as a potential therapy for mild cognitive impairment
    Diego Incontri Abraham, Félipe Esparza Salazar, Antonio Ibarra · 2022 · Brain and Cognition
55. CSF biomarkers in dementia: longitudinal aspects and combination with MRI
    Femke H. Bouwman · 2008 · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam)
56. Soluble Amyloid-Beta Isoforms Predict Downstream Alzheimer’s Disease Pathology
    Guilherme Povala, Bruna Bellaver, Marco Antônio De Bastiani, Wagner Scheeren Brum, Pâmela C.L. Ferreira, Andrei Bieger, Tharick Ali Pascoal, Andréa Lessa Benedet, Diogo Onofre Souza, Ricardo M. Araujo et al. · 2021 · Research Square
57. ALTERATIONS OF ZINC TRANSPORTERS IN ALZHEIMER'S DISEASE
    Ganna Lyubartseva A · 2009 · UKnowledge (University of Kentucky)
58. Biomarkers in Disease Diagnosis and Treatment
    Ralf Hoffmann · 2006 · Kluwer Academic Publishers eBooks
59. About Array Processing Methods for Image Segmentation
    Julien Marot, Caroline Fossati, Yannick Caulier · 2009 · InTech eBooks
60. Identification of Novel Fluid Biomarkers for Alzheimer's Disease
    Rebecca Craig‐Schapiro · 2012 · Open Scholarship Institutional Repository (Washington University in St. Louis)
61. What does it take to stay healthy past 100?
    Joseph L. Price · 2008 · Neurobiology of Aging
62. β-secretase: Physiological Role and Target Validation
    Fiona M. Laird, Mohamed H. Farah, Hey‐Kyoung Lee, Alena V. Savonenko, Donald L. Price, Philip C. Wong · 2007 · Springer eBooks
63. Interactive mechanism between beta-amyloid process, alfa7 nicotinic receptor, glial cell activation and oxidative stress in Alzheimer's disease
    Wenfeng Yu · 2006 · Figshare
64. Why age (and timing) really matters in developing drugs for neurodegenerative disease
    David Morgan, Amanda Smith · 2011 · Therapy
65. Neuronal protection by a variant of GAPDH pseudogene P44 in AD
    Sara O. Mason, Christopher Shane Theisen, Norbert W. Seidler · 2012 · Advances in Alzheimer s Disease
66. Beta-amyloid processing and alpha7 neuronal nicotinic acetylcholine receptors in Alzheimer s disease-related mouse models : Interactive mechanisms with focus on new drug targets
    Monika M. Hedberg · 2009 · Figshare
67. Cerebrovascular contributions to amnestic mild cognitive impairment
    Charles S DeCarli, Adriane B. V. Mayda, Christine Wu Nordahl · 2009 · Cambridge University Press eBooks
68. SPECIFIC AMYLOID-BETA OLIGOMERS IN HUMAN CEREBROSPINAL FLUID
    Maureen Handoko · 2012 · University of Minnesota Digital Conservancy (University of Minnesota)
69. Neuropsychological Function in Relation to Structural and Functional Brain Changes in Alzheimer’s Disease
    Eva Elgh · 2004 · KTH Publication Database DiVA (KTH Royal Institute of Technology)
70. Diet-Induced Ketosis and Calorie Restriction in Mouse Models of Alzheimer's Pathology
    Milene Lara Brownlow · 2013 · Digital Commons - University of South Florida (University of South Florida)
71. Delirium in the elderly: biomarkers and outcomes
    Joost Witlox · 2012 · UvA-DARE (University of Amsterdam)
72. MRI correlates of vascular cerebral lesions and cognitive impairment
    Elisabeth C.W. van Straaten · 2008 · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam)
73. Toward improving the diagnosis of Alzheimer's Disease
    Martin J. Sadowski · 2010
74. BACE1,aMajorDeterminantofSelectiveVulnerabilityofthe BraintoAmyloid-Amyloidogenesis,isEssentialfor Cognitive,Emotional,andSynapticFunctions
    Fiona M. Laird, Vassilis E. Koliatsos, David Borchelt · 2005
75. Modeling the Early Identification and Intervention of Alzheimer’s Disease
    Tzeyu L. Michaud · 2015 · University of Minnesota Digital Conservancy (University of Minnesota)
76. Discussing my romantic problems with my best friend: Longitudinal examinations of relationship work in younger and older couples
    Jakob F. Jensen · 2014
77. TC e risco cognitivo Uma prospecção no idoso do Vale do Tejo
    Ciências da Saúde · 2011
78. A Morphological Approach to the Longitudinal Detection of Dementia
    Najoung Kim, Jong Cheol Park · 2016 · HCI Korea
79. Imagerie de l’Alzheimer : quoi de neuf ?
    Pierre Payoux · 2013 · Médecine Nucléaire
80. Effects of Single Doses of Avagacestat (BMS-708163) on Cerebrospinal Fluid Ab Levels in Healthy Young Men
    Gary TongLorna · 2012
81. Non-additive effects of age, MCI and APOE on measures of the attentional reorienting system
    Peter Strassegger · 2011 · NORA - Norwegian Open Research Archives
82. Outils d'évaluation de l'observance de la personne âgée : vers la construction d'une nouvelle échelle Evaluation tools of drug adherence for elderly subjects: towards a new pattern of scale
    Julien Vejux, Kevin Galéry, A. Y. Ghali, Laure de Decker, Gilles Berrut · 2014
83. Emerging Principles and Biomarkers in In Vitro Diagnostics for Alzheimer's Disease
    Renee D. Wegrzyn · 2012 · Frontiers in neuroscience
84. The lived experience of dementia
    Shirley Nurock · 2017
85. Section summary and perspectives: Translational medicine in neurology
    James E. Barrett, Joseph T. Coyle · 2012 · Cambridge University Press eBooks
86. PET studies on disease progression and treatment efficacy in Alzheimer’s disease and mild cognitive impairment
    Aren Okello · 2011 · Spiral (Imperial College London)
87. Quantitative analysis of neuropathological alterations in two transgenic mouse models of Alzheimer's disease
    Anastasiia Kurdakova · 2016
88. Investigating Simulated Driving Behaviour and Brain Activation in Mild Cognitive Impairment
    Megan A. Hird · 2016 · TSpace (University of Toronto)
89. SLEEP ALTERATIONS IN MOUSE GENETIC MODELS OF HUMAN DISEASE
    Sethi, Mansi · 2016 · UKnowledge (University of Kentucky)
90. Intraindividual variability and severity of cognitive impairment
    Tanya Louise. Lentz · 2003 · UVic’s Research and Learning Repository (University of Victoria)
91. In Vitro and In Vivo Studies on Antibodies - N-terminally Truncated Abeta in the 5XFAD Mouse Model
    Bernhard Clemens Richard · 2015
92. Hormonal and non-hormonal factors associated with cognition in post-menopausal women
    Mark A. Rodrigues · 2004 · UWA Profiles and Research Repository (UWA)
93. The Regulation of Extracellular Amyloid-_ Levels by Ionotropic Glutamatergic Transmission in an Alzheimer
    Jane C. Hettinger · 2017 · Open Scholarship Institutional Repository (Washington University in St. Louis)
94. DEPLETION OF TDP-43 ACCELERATES NEURODEGENERATION IN AN ALZHEIMER’S MOUSE MODEL, INDEPENDENT OF BETA-AMYLOID PLAQUE BURDEN
    Katherine D. LaClair · 2016
95. Cytoskeletal protein dysfunction and oxidative modification in Alzheimer’s disease
    Angela M. Boutté · 2005
96. Cross-Sectional and Longitudinal Comparisons of Biomarkers and Cognition Among Asymptomatic Middle-Aged Individuals with a Parental History of Either Autosomal Dominant or Late Onset Alzheimer Disease
    Chengjie Xiong, Lena M. McCue, Virginia Buckles, Elizabeth Grant, Folasade Agboola, Dean Coble, Randall John Bateman, Anne M. Fagan, Tammie L.S. Benzinger, Jason J. Hassenstab et al. · 2021 · SSRN Electronic Journal
97. Neuroimaging Studies of the Dwindling Self: Neurodegenerative Dementias
    Andrea Nani, Andrea E. Cavanna · 2013 · Springer eBooks
98. Information and communication technologies for the improvement of cognitive function in healthy older adults: a systematic review protocol
    Roland Pastells‐Peiró, Helena Fernández‐Lago, Esther Rubinat, Filip Bellon, Jordi Martínez‐Soldevila, Montserrat Gea‐Sánchez · 2021 · BMJ Open
99. Current Awareness
    2002 · International Journal of Geriatric Psychiatry
100. Cognition and translational research
     Francesca Maria Rubulotta, Ahmed Ezzat, Zena Radi, Federico Billotta · 2022 · Elsevier eBooks